Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial
Title:
Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial
Author:
O’Donoghue, Michelle L. Glaser, Ruchira Aylward, Philip E. Cavender, Matthew A. Crisp, Adam Fox, Keith A.A. Laws, Ian Lopez-Sendon, Jose L. Steg, P. Gabriel Theroux, Pierre Sabatine, Marc S. Morrow, David A.